Increasing costs, complexity, regulatory demands and decentralization of clinical trials are driving PE dealmakers to invest more in designers of clinical research technologies.
Tech providers and products in the segment range from patient recruitment and supply automation to life science tools for clinical trial analyses.
Starting with the most recent, here are five deals in the clinical research technology sector that PE Hub has covered over the last five months:
